Laurus Labs (BOM:540222) E10: ₹10.43 (As of Mar. 2026)


BOM:540222 Laurus Labs Ltd BOM:540222
71 GF Score
Price ₹1,529.20
GF Value ₹702.13
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Laurus Labs E10?

Laurus Labs BOM:540222 -0.81% 71 E10 is ₹10.43 as of Mar. 2026. GuruFocus rates BOM:540222 with a GF Score™ of 71/100 and a GF Value™ of ₹702.13 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Laurus Labs's adjusted earnings per share data for the three months ended in Mar. 2026 was ₹5.170. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹10.43 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-07-07), Laurus Labs's current stock price is ₹1529.20. Laurus Labs's E10 for the quarter that ended in Mar. 2026 was ₹10.43. Laurus Labs's Shiller PE Ratio of today is 146.62.

During the past 13 years, the highest Shiller PE Ratio of Laurus Labs was 147.83. The lowest was 81.26. And the median was 100.12.


Laurus Labs  (BOM:540222) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Laurus Labs's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=1529.20/10.43
=146.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Laurus Labs was 147.83. The lowest was 81.26. And the median was 100.12.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Laurus Labs E10 Related Terms


Laurus Labs E10 Historical Data

* Premium members only.

The historical data trend for Laurus Labs's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Laurus Labs E10 Chart

Laurus Labs Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 10.43

Laurus Labs Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 9.55 9.82 10.11 10.43

BOM:540222 vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Laurus Labs's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Laurus Labs Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Laurus Labs's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Laurus Labs's Shiller PE Ratio falls into.


BOM:540222
71GF Score
Laurus Labs Ltd BOM:540222
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Laurus Labs E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Laurus Labs's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=5.17/164.2724*164.2724
=5.170

Current CPI (Mar. 2026) = 164.2724.

Laurus Labs Quarterly Data

per share eps CPI Adj_EPS
201606 0.518 105.961 0.803
201609 0.976 105.961 1.513
201612 0.896 105.196 1.399
201703 1.350 105.196 2.108
201706 0.732 107.109 1.123
201709 0.916 109.021 1.380
201712 0.656 109.404 0.985
201803 0.852 109.786 1.275
201806 0.310 111.317 0.457
201809 0.306 115.142 0.437
201812 0.334 115.142 0.477
201903 0.810 118.202 1.126
201906 0.282 120.880 0.383
201909 1.060 123.175 1.414
201912 1.380 126.235 1.796
202003 2.070 124.705 2.727
202006 3.210 127.000 4.152
202009 4.500 130.118 5.681
202012 5.070 130.889 6.363
202103 5.500 131.771 6.857
202106 4.480 134.084 5.489
202109 3.740 135.847 4.523
202112 2.850 138.161 3.389
202203 4.280 138.822 5.065
202206 4.660 142.347 5.378
202209 4.320 144.661 4.906
202212 3.760 145.763 4.237
202303 1.900 146.865 2.125
202306 0.460 150.280 0.503
202309 0.680 151.492 0.737
202312 0.430 152.924 0.462
202403 1.400 153.035 1.503
202406 0.230 155.789 0.243
202409 0.370 157.882 0.385
202412 1.710 158.323 1.774
202503 4.330 157.552 4.515
202506 3.020 159.755 3.105
202509 3.610 162.289 3.654
202512 4.650 163.281 4.678
202603 5.170 164.272 5.170

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹10.43 mean?
Laurus Labs (BOM:540222) has a E10 of ₹10.43 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Laurus Labs and its competitors.
Is Laurus Labs' E10 too high?
Laurus Labs' current E10 is ₹10.43. Overall, Laurus Labs has a GF Score™ of 71/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Laurus Labs' E10 compare to ZTS and UTHR?
Laurus Labs' E10 of ₹10.43 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Laurus Labs and its competitors. Laurus Labs's current E10 is ₹10.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Laurus Labs stock overvalued right now?
Based on GuruFocus' analysis, Laurus Labs (BOM:540222) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹702.13, compared to a current price of ₹1,529.20 — trading 117.8% above its estimated fair value. The current E10 is ₹10.43. Laurus Labs' overall GF Score™ is 71/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Laurus Labs (BOM:540222), the current E10 is ₹10.43 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Laurus Labs (BOM:540222) Overvalued in 2026?

Based on GuruFocus' analysis, Laurus Labs stock appears to be overvalued. The current stock price of ₹1,529.20 is trading 117.8% above its estimated GF Value™ of ₹702.13. GuruFocus considers Laurus Labs to be Significantly Overvalued.

Key valuation signals for BOM:540222:

  • E10: ₹10.43
  • GF Value™: ₹702.13 vs. price of ₹1,529.20 (117.8% above fair value)
  • GF Score™: 71/100 with 6 warning signs

No single metric tells the full story. See the BOM:540222 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Laurus Labs Business Description

Other Exchanges LAURUSLABS:India
Address Road No.1, Jubilee Hills, Plot No.103, Hyderabad, TG, IND, 500033
Laurus Labs Ltd is a pharmaceutical company based in India. It provides active pharmaceutical ingredients (API) including intermediates, Generic Finished dosage forms (FDF), and Contract Research services. The entity develops APIs and intermediates for select, high-growth antiretrovirals, Hepatitis C and Oncology. It also manufactures APIs in other therapeutic areas, such as anti-asthma, ophthalmology, anti-diabetics, cardiovascular, and proton pump inhibitors, among others. The company has its business presence in India and Outside India of which it derives a majority of revenue from Outside India. The company generates revenue from the sale of API, Intermediates and Formulations, Contract research services, and others.
71GF Score

Get the complete analysis for BOM:540222

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,529.20
Price
₹702.13
GF Value